US · Healthcare

Pasithea Therapeutics Corp (KTTA)

Biotechnology

Pasithea Therapeutics Corp (KTTA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KTTA

P/E ratio

25.00

Pasithea Therapeutics Corp (KTTA) — FAQ

What is KTTA's P/E ratio?

The price-to-earnings (P/E) ratio for Pasithea Therapeutics Corp (KTTA) is 25.00 (data as of 2026-05-23).

Does Pasithea Therapeutics Corp pay a dividend?

Dividend yield is not available in the current snapshot for Pasithea Therapeutics Corp (KTTA). Check the MyAverix Finance app for the latest dividend data.

What sector is Pasithea Therapeutics Corp in?

Pasithea Therapeutics Corp (KTTA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is KTTA listed on?

KTTA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)